Ionotropic cross-linked chitosan microspheres for controlled release of ampicillin

被引:144
作者
Anal, AK
Stevens, WF
Remuñán-López, C
机构
[1] Massey Univ, Riddet Ctr, Palmerston North, New Zealand
[2] Asian Inst Technol, Bangkok 12120, Thailand
[3] Mahidol Univ, Dept Sci, Bangkok, Thailand
[4] Univ Santiago Compostela, Fac Pharm, Dept Pharm & Pharmaceut Technol, Santiago De Compostela, Spain
关键词
ampicillin; chitosan microspheres; controlled release; emulsification-solvent evaporation; spray-drying; tripolyphosphate;
D O I
10.1016/j.ijpharm.2006.01.043
中图分类号
R9 [药学];
学科分类号
1007 [药学];
摘要
The solubility of non cross-linked chitosan in weak acid solutions restricts its utility in microspheres for drug delivery. The primary aim of this study was to produce pentasodium tripolyphosphate cross-linked chitosan microspheres with higher acid resistance for controlled release of ampicillin. The microspheres were prepared by two different microencapsulation procedures (by emulsification and by spray-drying) and characterized by their particle size, surface morphology, stability, drug entrapment efficiency and drug release. The size of the microspheres was < 10 mu m with a narrow size distribution. The entrapment of ampicillin in the microspheres was more than 80%. Stability of uncross-linked and cross-linked microspheres was affected by the pH of simulated gastric fluid (SGF, pH 1.2) and simulated intestinal fluid (SIF, pH 7.5). The inclusion of the enzymes pepsin and pancreatin did not affect the stability of the microspheres. The inclusion of lysozyme in phosphate buffer saline resulted in increased solubilization. The release of the drug was affected by cross-linking of microspheres with tripolyphosphate (TPP). The cross-linked microspheres were more stable in simulated gastric fluid and showed slower but sustained release of ampicillin. The antimicrobial activity of the released ampicillin was confirmed by Staphylococcus aureus bioassay. (c) 2006 Elsevier B.V. All rights reserved.
引用
收藏
页码:166 / 173
页数:8
相关论文
共 33 条
[1]
Chitosan-alginate multilayer beads for gastric passage and controlled intestinal release of protein [J].
Anal, AK ;
Bhopatkar, D ;
Tokura, S ;
Tamura, H ;
Stevens, WF .
DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY, 2003, 29 (06) :713-724
[2]
Chitosan-alginate multilayer beads for controlled release of ampicillin [J].
Anal, AK ;
Stevens, WF .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2005, 290 (1-2) :45-54
[3]
BAILEY RW, 1970, DIAGNOSTIC MICROBIOL, P289
[4]
Berthold A, 1996, STP PHARMA SCI, V6, P358
[5]
Ionotropic alginate beads for controlled intestinal protein delivery: Effect of chitosan and barium counter-ions on entrapment and release [J].
Bhopatkar, D ;
Anal, AK ;
Stevens, WF .
JOURNAL OF MICROENCAPSULATION, 2005, 22 (01) :91-100
[6]
PSEUDOEPHEDRINE HCL MICROSPHERES FORMULATED INTO AN ORAL SUSPENSION DOSAGE FORM [J].
BODMEIER, R ;
CHEN, H ;
TYLE, P ;
JAROSZ, P .
JOURNAL OF CONTROLLED RELEASE, 1991, 15 (01) :65-77
[7]
PREPARATION AND EVALUATION OF DRUG-CONTAINING CHITOSAN BEADS [J].
BODMEIER, R ;
OH, KH ;
PRAMAR, Y .
DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY, 1989, 15 (09) :1475-1494
[8]
Conti B, 2000, STP PHARMA SCI, V10, P101
[9]
Characterization of crosslinked high amylose starch matrix implants -: 1.: In vitro release of ciprofloxacin [J].
Désévaux, C ;
Dubreuil, P ;
Lenaerts, V .
JOURNAL OF CONTROLLED RELEASE, 2002, 82 (01) :83-93
[10]
A multiple emulsion method to entrap a lipophilic compound into chitosan microspheres [J].
Genta, I ;
Perugini, P ;
Conti, B ;
Pavanetto, F .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1997, 152 (02) :237-246